FDA.reportPublic FDA data

Application 072011

Type
ANDA
Sponsor
SANDOZ

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001TRIAMTERENE AND HYDROCHLOROTHIAZIDEHYDROCHLOROTHIAZIDE; TRIAMTERENETABLET;ORAL50MG;75MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0781-1008Triamterene hydrochlorothiazideTriamterene and hydrochlorothiazideSandoz IncANDACurrent
0781-1008Triamterene hydrochlorothiazideTriamterene and hydrochlorothiazideSandoz IncANDACurrent
0781-5067Triamterene hydrochlorothiazideTriamterene and hydrochlorothiazideSandoz IncANDACurrent
0781-5067Triamterene hydrochlorothiazideTriamterene and hydrochlorothiazideSandoz IncANDACurrent
10544-080Triamterene hydrochlorothiazideTriamterene and hydrochlorothiazideBlenheim Pharmacal, Inc.ANDACurrent
21695-496Triamterene hydrochlorothiazideTriamterene and hydrochlorothiazideRebel Distributors CorpANDACurrent
43063-442Triamterene hydrochlorothiazideTriamterene and hydrochlorothiazidePD-Rx Pharmaceuticals, Inc.ANDACurrent
43063-442Triamterene hydrochlorothiazideTriamterene and hydrochlorothiazidePD-Rx Pharmaceuticals, Inc.ANDACurrent
43063-442Triamterene hydrochlorothiazideTriamterene and hydrochlorothiazidePD-Rx Pharmaceuticals, Inc.ANDACurrent
50090-2489Triamterene hydrochlorothiazideTriamterene and hydrochlorothiazideA-S Medication SolutionsANDACurrent
50090-3106Triamterene hydrochlorothiazideTriamterene and hydrochlorothiazideA-S Medication SolutionsANDACurrent
68001-215Triamterene hydrochlorothiazideTriamterene and hydrochlorothiazideBluePoint LaboratoriesANDACurrent